Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Diana Medgyesy

Concepts (51)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antimetabolites, Antineoplastic
4
2003
106
0.150
 Why?
Fluorouracil
5
2013
231
0.130
 Why?
Tegafur
5
2003
12
0.090
 Why?
Colorectal Neoplasms
4
2000
866
0.080
 Why?
Deoxycytidine
5
2013
220
0.080
 Why?
Oxonic Acid
4
2003
13
0.080
 Why?
Camptothecin
2
2000
138
0.070
 Why?
Uracil
4
2000
36
0.070
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2013
1963
0.070
 Why?
Capecitabine
5
2013
56
0.060
 Why?
Pyridines
4
2003
609
0.050
 Why?
Breast Neoplasms
2
2013
2382
0.050
 Why?
Prodrugs
2
1999
52
0.050
 Why?
Gastrointestinal Neoplasms
1
2003
73
0.040
 Why?
Folic Acid Antagonists
1
1999
8
0.040
 Why?
Leucovorin
4
2000
98
0.040
 Why?
Oxidoreductases
1
1999
91
0.040
 Why?
Antineoplastic Agents
2
1999
2214
0.030
 Why?
Enzyme Inhibitors
1
1999
820
0.030
 Why?
Drug Combinations
3
2003
396
0.030
 Why?
Dose-Response Relationship, Drug
2
2013
2028
0.030
 Why?
Stomatitis
1
2013
15
0.020
 Why?
Administration, Oral
3
2000
866
0.020
 Why?
Bevacizumab
1
2013
168
0.020
 Why?
Phenylurea Compounds
1
2013
119
0.020
 Why?
Niacinamide
1
2013
104
0.020
 Why?
Skin Diseases
1
2013
152
0.020
 Why?
Disease-Free Survival
1
2013
767
0.020
 Why?
Drug Administration Schedule
1
2013
782
0.020
 Why?
Fatigue
1
2013
364
0.020
 Why?
Kaplan-Meier Estimate
1
2013
969
0.020
 Why?
Double-Blind Method
1
2013
2062
0.020
 Why?
Antibodies, Monoclonal, Humanized
1
2013
992
0.020
 Why?
Treatment Outcome
3
2013
11772
0.010
 Why?
Disease Progression
1
2013
2864
0.010
 Why?
Area Under Curve
1
2003
331
0.010
 Why?
Organoplatinum Compounds
1
2000
65
0.010
 Why?
Clinical Trials, Phase II as Topic
1
2000
75
0.010
 Why?
Clinical Trials, Phase III as Topic
1
2000
116
0.010
 Why?
Dihydrouracil Dehydrogenase (NADP)
1
1999
5
0.010
 Why?
Aged
2
2013
26153
0.010
 Why?
Humans
7
2013
145474
0.010
 Why?
Infusions, Intravenous
1
1998
428
0.010
 Why?
Middle Aged
2
2013
36215
0.010
 Why?
Adult
2
2013
40777
0.010
 Why?
Neoplasm Metastasis
1
1998
688
0.010
 Why?
Randomized Controlled Trials as Topic
1
2000
1747
0.010
 Why?
Female
3
2013
78844
0.010
 Why?
Time Factors
1
2003
7123
0.010
 Why?
Animals
2
1999
38030
0.000
 Why?
Male
2
2003
72842
0.000
 Why?
Medgyesy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (51) concept(s)
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)